Sivers Semiconductors: Capital Infusion Buys Time as Investors Weigh Dilution Against a Growing Order Book

Sivers Semiconductors posts wider Q2 loss on transition costs, but order pipeline surges 268% to $1.2B, signaling future growth.

The arithmetic at Sivers Semiconductors is unforgiving, even if the strategic direction is increasingly clear. The Swedish chipmaker closed the second quarter of 2026 with net sales of SEK 53.8 million and an adjusted EBITDA shortfall of SEK 35.5 million — a loss that underscores just how expensive the transition from development-stage engineering to recurring product revenue has become. The market's verdict was swift: shares fell 13 percent on the day of the report, settling at EUR 2.48 in one account of the trading session, while another put the closing price at EUR 2.86. Either way, the stock now sits well below its 50-day moving average of EUR 4.07.

The headline revenue figure tells only part of the story. While total sales declined 12 percent year-on-year, the underlying hardware and product segment actually grew 13 percent — or 18 percent on a currency-adjusted basis. That divergence reflects a deliberate strategic choice: management is steering away from one-off NRE (non-recurring engineering) contracts toward repeatable production ramps. The near-term pain is visible in the net loss, which ballooned from SEK 50.6 million to SEK 115 million. But a chunk of that deterioration is technical rather than operational. A non-cash social security charge of SEK 42.9 million, triggered by the sharp rise in the company's share price during the quarter, distorted the reported figures considerably. These payroll-related levies tied to employee stock programs say little about the underlying health of the business, yet they make the income statement look far worse than the operating reality.

What gives the bulls ammunition is the order pipeline. Management pegged the combined order and opportunity pipeline at USD 1.2 billion as of July — a 268 percent jump from the end of 2025. Tangible evidence of momentum arrived in the form of a production order from ALL.SPACE worth USD 8.2 million for Ka-band beamforming chips, supporting a manufacturing ramp slated to begin in 2027. The company has also been busy deepening its technological moat: a program with SemiNex Corporation for next-generation indium phosphide light sources targeting AI data-center interconnects kicked off roughly two weeks ago, alongside an engineering engagement valued at USD 3.4 million. A separate strategic collaboration with GlobalFoundries on advanced silicon photonics for AI infrastructure rounds out the roadmap.

None of this comes cheap. To fund the losses and the build-out, Sivers has raised gross proceeds of SEK 825 million through two targeted equity placements, and a USD 12 million convertible note from Bootstrap Europe has been converted into equity. The dilution to existing shareholders is real and was likely a factor in the post-report selling. Adding to the overhang, media reports from roughly three weeks ago flagged a possible undisclosed share sale by a major shareholder and fresh short positions — concerns that have lingered and muted any positive reaction to the hardware growth. The recent warrant exercise by Bootstrap Europe, which saw 1.66 million shares acquired at SEK 4.53 apiece, fits into the same pattern of active capital management.

The stock's slide predates the quarterly numbers. Over the seven trading days leading into the report, the shares had already lost 15 percent, and the week prior to the release saw a 26 percent decline. Since the SemiNex announcement, the stock has shed 22.1 percent. Management held an online presentation the evening after the results to walk investors through the figures, but the mood remains cautious.

There are structural changes afoot beyond the balance sheet. The board has been expanded with the addition of Joakim Nideborn and Helena Svancar, and the company continues to prepare for a dual listing in the United States, targeted for the first half of 2027. Management has pointed to the fourth quarter of 2026 as the expected inflection point for revenue, when customer programs are slated to move into production.

For now, investors are left weighing a weak near-term earnings picture against an order book that has grown 268 percent in six months. The pipeline is a credible promise, but until it converts into margin improvement, every quarterly print will be scrutinized for signs that the pivot is actually working. The capital raise buys time — the question is whether the market's patience will last as long as the runway.